Anticancer effect of joboksansam, Korean wild ginseng germinated from bird feces  by Park, Jae Gwang et al.
lable at ScienceDirect
J Ginseng Res 40 (2016) 304e308Contents lists avaiJournal of Ginseng Research
journal homepage: http : / /www.ginsengres.orgResearch articleAnticancer effect of joboksansam, Korean wild ginseng germinated
from bird feces
Jae Gwang Park 1,q, Wie-Soo Kang 2,q, Kyung Tae Park 3, Dong Jun Park 3,
Adithan Aravinthan 4, Jong-Hoon Kim4,**, Jae Youl Cho 1,*
1Department of Genetic Engineering, Sungkyunkwan University, Suwon, Korea
2Korea Bird Wild Ginseng Co., Namyangju, Korea
3 School of Bioscience and Biotechnology, Kangwon National University, Chuncheon, Korea
4Department of Physiology, College of Veterinary Medicine, Chonbuk National University, Iksan, Koreaa r t i c l e i n f o
Article history:
Received 26 January 2016
Received in Revised form
29 January 2016
Accepted 3 February 2016
Available online 17 February 2016
Keywords:
anticancer activity
cytotoxicity
joboksansam
Panax ginseng
survival enzyme* Corresponding author. Jae Youl Cho, Department
** Corresponding author. Jong-Hoon Kim, Departme
E-mail addresses: jhkim1@chonbuk.ac.kr (J.-H. Kim
q
J.G. Park and W.-S. Kang contributed equally to th
p1226-8453 e2093-4947/$ e see front matter Copyrig
license (http://creativecommons.org/licenses/by-nc-n
http://dx.doi.org/10.1016/j.jgr.2016.02.002a b s t r a c t
Background: Joboksansam, Korean bird wild ginseng, is an artiﬁcially cultivated wild ginseng germinated
from bird feces. Although numerous pharmacologic activities of wild ginsengs have been reported, the
beneﬁcial effect of joboksansam in cancer has not been elucidated. In this study, we investigated the
in vivo and in vitro anticancer activities of joboksansam powder.
Methods: To evaluate the in vivo anticancer activity of joboksansam, we established a xenograft mouse
model bearing RMA cell-derived cancer. Direct cytotoxicity induced by joboksansam powder was also
investigated in vitro using (3-4-5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide (MTT) assay.
The inhibitory activity of this powder on the activation of cell survival signaling involving Akt and Src
was examined with immunoblot analysis.
Results: Joboksansam powder displayed strong inhibitory activity against the increased tumor size,
increased weight of total body and cancer tissues, and mortality of tumor-bearing mice. Joboksansam
powder also suppressed the activation of survival regulatory enzymes Akt and Src, as assessed by
phosphorylation levels in the immunoblot analysis of tumor tissues. Interestingly, the viability of RMA
cells in vitro was directly decreased by joboksansam treatment.
Conclusion: Overall, our results strongly suggest that joboksansam powder has the potential to protect
against cancer generation by direct cytotoxic effects on cancer cells resulting from suppression of cell
survival signaling.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The root of Korean ginseng (Panax ginsengMeyer) has been used
for 20 centuries in Korea, China, and Japan, and its beneﬁcial ac-
tivities, including antioxidative, anti-inﬂammatory, antidiabetic,
antiobesity, and anticancer effects, have beenwidely demonstrated
[1,2]. Recent systemic studies have improved our understanding of
the pharmacologic mechanisms and active components in
P. ginseng roots. The efﬁcacy value of wild ginseng was indicated to
be higher than that of cultivated ginseng, although the productionof Physiology, College of Veterinar
nt of Genetic Engineering, Sungky
), jaecho@skku.edu (J.Y. Cho).
is work.
ht  2016, The Korean Society of G
d/4.0/).rate of wild ginseng was much lower. To increase the production
rate of wild ginseng under cultivated conditions, we recently
developed new cultivation methods for wild ginseng and obtained
increased germination rates by preparing digested seeds in the
feces of birds that eat ginseng berries, as in the natural process of
the wild ginseng life cycle. Under these conditions, joboksansam
displayed higher levels of germination than another artiﬁcially
cultivated wild ginseng, sanyangsansam [3]. However, the phar-
macologic value of joboksansam has not been fully elucidated, even
though cultivation of this ginseng is very similar to the naturaly Medicine, Chonbuk National University, Iksan 54596, Korea.
unkwan University, Suwon 16419, Korea.
inseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
Table 1
Instrument and working conditions for ginsenoside analysis by high-performance
liquid chromatography (HPLC)
Instrument Shimadzu LC-10AT HPLC
system
Column YMC AM303, 4.6  250
mm
Detector UV/VIS detector (203 nm)
Solvent A H2O
Solvent B Acetonitrile
Injection volume 20 mL
Flow rate 1 mL/min
Gradient elution system %A %B
Time (min) 0 20 80
30 20 80
35 35 65
60 65 45
65 20 80
70 20 80
UV/VIS, Ultraviolet/visible.
J.G. Park et al / Anticancer effect of joboksansam 305product. In this study, our aim was to test the pharmacologic ac-
tivity of joboksansam by examining its anticancer activity in a
xenograft mouse model bearing RMA (murine T cell lymphoma)
cell-derived cancer.
2. Materials and methods
2.1. Materials
Joboksansam (10 yr old) was cultivated in Namyangju (Kyunggi,
Korea). Sodium carboxymethylcellulose (Na CMC), dimethyl sulf-
oxide (DMSO), and (3-4-5-dimethylthiazol-2-yl)-2-5-
diphenyltetrazolium bromide (MTT) were obtained from Sigma
Chemical Co. (St. Louis, MO, USA). Standard ginsenosides were
purchased from Ambo Institute (Daejeon, Korea). Fetal bovine
serum and RPMI 1640 were purchased from Gibco (Grand Island,
NY, USA). RMA cells used in the present experiments were obtained
from the American Type Culture Collection (Rockville, MD, USA). All
other chemicals were from Sigma. Total or phospho-speciﬁc anti-
bodies were purchased from Cell Signaling Technology (Beverly,
MA, USA). Plasmid constructs containing Src, AKT, and b-actinwere
used as reported previously [4e6].
2.2. Preparation of joboksansam powder
An ultraﬁne air mill (Turbo Mill, HKP-05; Korea Energy Tech-
nology, Seoul, Korea) was used to obtain ultraﬁne powder as re-
ported previously [7,8]. The coarse powders prepared previously
were pulverized into ultraﬁne powder particles with sizes in the
range of 0.1e50 mm in a milling chamber with a hot jacket (180C).
Feeding rate and circumferential velocity of the impeller in the
grinding zone were ﬁxed at 3 kg/h and 100m/s, respectively.
Simultaneously, a centrifugal air classiﬁcation system separated the
powders according to particle size. The ultraﬁne Joboksansam
powder obtained was stored in a desiccator until use.
2.3. Cell culture
RAW264.7 and HEK293 cells were cultured in RPMI 1640 and
Dulbecco’s modiﬁed Eagle’s medium, respectively, supplemented
with 10% heat-inactivated fetal bovine serum and 1% antibiotics
(penicillin and streptomycin) at 37C under 5% CO2 [9].
2.4. Drug treatment
For in vivo experiments, joboksansam powder was suspended
with 0.5% Na CMC. For in vitro cytotoxicity tests, joboksansam
powder was suspended in 100% DMSO at a concentration of
100 mg/mL, and the solution was ﬁltered prior to dilution with
culture medium as reported previously [10,11].
2.5. Xenograft mouse model experiments
All animal experiments were carried out in accordance with the
National Research Council’s Guidelines (IACUC, Korea) for the Care
and Use of Laboratory Animals. The experimental protocol was
approved by the Animal Experiments Committee of Sungkyunkwan
University. C57BL/6 mice (female, 5 wk old; Orient-bio, Sungnam,
Republic of Korea) were used as our xenograft animal model. Mice
were housed individually on a 12-h day/12-h night cycle at 23e
27C and had access to food and water. Mice were randomly
divided into two groups (n ¼ 14/group): (1) a vehicle control group
(n ¼ 10), wherein animals received oral administration of 0.5% Na
CMC; (2) a joboksansam powder treatment group (n¼ 14), wherein
animals received oral administration of joboksansam powder(400 mg/kg). To produce tumors, each mouse was implanted with
RMA cells (1106 cells per animal) subcutaneously in the back next
to the right hind leg. Joboksansam powder or vehicle was adminis-
tered orally fromDay 1 to Day 14. On the indicated days, the tumors
were identiﬁed and measured with a standard caliper. Tumor vol-
ume was calculated as follows: tumor volume (mm3)¼ [tumor
length (mm) tumor width (mm)2]/2. Mice were sacriﬁced at Day
33.2.6. Cell cytotoxicity
The cytotoxicity of joboksansam powder against RMA cells was
evaluated using a conventional MTT assay as previously described
[12]. Brieﬂy, the cells were plated in 96-well plates at a density of
5  104 cells/well and treated with different concentrations of
joboksansam powder (0, 200, 400, and 800 mg/mL) for 24 h.
Absorbance was measured at 540 nm using a microplate reader.2.7. Immunoblot analysis of total lysate from tumor
Total lysates prepared from cancer tissue were subjected to
Western blot analysis of total or phospho-forms of Src and AKT as
reported previously [13]. Total or phosphorylated forms of Akt, Src,
and b-actin were visualized as described previously [14].2.8. High-performance liquid chromatography analysis
For determination of ginsenosides in joboksansam powder,
high-performance liquid chromatography (HPLC) was conducted as
stated previously. The exact conditions of HPLC are described in
Table 1.2.9. Statistical analysis
All data presented in this paper are the mean  standard devi-
ation of an experiment performed with 14 (Fig. 1) or three (Figs. 2e
4) replicates. For statistical comparisons, the results were analyzed
using analysis of variance/Scheffe post hoc test and KruskaleWallis/
ManneWhitney tests. A p < 0.05 was considered statistically sig-
niﬁcant. All statistical tests were carried out using the computer
program SPSS (Version 22.0, 2013, IBM Corp., Armonk, NY, USA).
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Fig. 1. Anticancer effect of joboksansam powder in a xenograft mouse bearing RMA cell-derived cancer. Mice were injected with RMA cells (1 106 cells per mouse) subcutaneously
into the back next to the right hind leg. Mice were then sorted into two groups (n ¼ 14/group) and orally administered joboksansam (400 mg/kg) or vehicle. (A) Tumor size was
measured on the indicated days until the experimental endpoint. (B) Weight of mice was measured on each indicated day. (C) Photographs of xenograft mice bearing RMA cell-
derived cancer. (D) The cancer tissues were measured (left panel) and photographed (right panel) at 33 d. (E) Mortality of mice was determined on the indicated days. *p < 0.05,
**p < 0.01 compared with control.
J Ginseng Res 2016;40:304e3083063. Results and discussion
To determine whether joboksansam suppresses the develop-
ment of cancer, we established a xenograft mouse model bearing
RMA cell-derived cancer according to a previously published
method [15]. Although RMA cells are a subline of the Raucher virus-
induced T cell lymphoma RBL-5 (H-2b) [16], the mouse model
exhibited a striking increase in tumor size and animal body weightp-Akt
Joboksansam (400 mg/kg)
Akt
p-Src
Src
Control 
1         2         3Animal No. 1         2         3
-actin
Fig. 2. Effect of joboksansam powder on the phosphorylation level of survival
signaling proteins. Levels of total and phosphorylated forms of Akt, Src, and b-actin in
RMA tumor tissues were determined by immunoblot analysis.(Fig. 1), as reported previously [15]. Interestingly, orally adminis-
tered joboksansam powder (400 mg/kg) clearly suppressed the
enhanced tumor size (Fig. 1A), suppressed the increased weight of
total body and cancer tissues (Figs. 1Be1D), and decreased the
mortality of tumor-bearing mice (Fig. 1E), implying that orallyFig. 3. Effect of joboksansam on the viability of RMA cells. Viability of RMA cells
treated with joboksansam for 24 h was determined by the MTT assay. **p < 0.01
compared with the control group. MTT, (3-4-5-Dimethylthiazol-2-yl)-2-5-
diphenyltetrazolium bromide.
Fig. 4. HPLC proﬁle of joboksansam. Ginsenosides from joboksansam powder were identiﬁed by HPLC analysis. HPLC, High performance liquid chromatography.
J.G. Park et al / Anticancer effect of joboksansam 307administered joboksansam might have anticancer activity. To date,
numerous studies have demonstrated that wild and cultivated
ginsengs, as well as processed ginsengs (red ginseng and fermented
ginseng with Phellinus linteus), are good herbal medicines with
anticancer activity [17,18]. Because the mass and size of tumors
were markedly decreased under our conditions, we next investi-
gated whether the powder had an antiproliferative effect on cancer
cells. For this purpose, we measured the activation levels of cell
survival regulatory proteins such as Akt and Src [19,20] by immu-
noblot analysis using phospho-speciﬁc antibodies that speciﬁcally
recognize their active forms. As shown in Fig. 2, the levels of
phospho-forms of Akt and Src were remarkably decreased in the
joboksansam-treated group compared with the control group,
implying that survival signaling might be decreased in
joboksansam-treated tumor cells. As with other ginseng roots,
these results strongly suggest that wild ginseng as well as jobok-
sansam could be a useful herbal medicine for protection from
tumorigenic responses. As cancer is one of the major diseases
affecting human life span in most countries [21], our data indicate
that long-term administration of ginseng might help lower the
incidence of cancer diseases, as reported previously in the case of
colorectal cancer [18].
Ginseng-derived anticancer activity is generally known to result
from activation of the body’s antitumor immune regulatory cells,
including natural killer cells andmacrophages [22e24]. In addition,
speciﬁc components in ginseng or ginseng-derived preparations
such as compound K, ginsenoside (G) Rh1, G-F2, G-Rg3, and G-Rp1
were shown to induce apoptosis of cancer cells and were proposed
to contribute to the anticancer properties of ginseng [25e29].
Therefore, we examined whether the antiproliferative activity of
joboksansam powder involves a direct cytotoxic effect using an
in vitro cell proliferation assay. Intriguingly, treatment with jobok-
sansam at 400 and 800 mg/mL suppressed the viability of RMA cells
in a dose-dependent manner, implying that direct cytotoxicity
induced by joboksansam might be one of the major factors
contributing to its anticancer activity. Indeed, HPLC analysis clearly
indicated that apoptosis-inducing ginsenosides [e.g., compound K
(CeK), G-Rg3, and G-Rh2] are present in joboksansam powder
(Table 2 and Fig. 4). The compounds in joboksansam powder thatTable 2
Composition of ginsenosides in joboksansam powder
Ginsenosides (mg/g dry weight)
Rg1 Re Rf Rb1 Rb2 Rc Rd Rg3 Rh2 CeK total
3.3 0.74 0.70 1.56 0.48 0.96 0.78 0.92 0.70 1.30 13.44
CeK, Compound K.contribute to its active anticancer activity and the underlying
antiproliferative mechanism have not yet been veriﬁed. Therefore,
we will further investigate major anticancer components using
activity-guided fractionation with in vitro cell proliferation assays
and apoptosis-inducing patterns using apoptosis biomarkers such
as AMP-activated protein kinase, Mcl-1, and caspases [30,31].
In summary, joboksansam powder displayed strong anticancer
activity in a xenograft mouse model bearing RMA cell-derived
cancer and exhibited direct suppression of RMA cell viability.
Immunoblot analysis indicated that survival signaling pathways
composed of AKT and Src are inhibited by joboksansam treatment.
These results strongly imply that joboksansam might have a po-
tential role in preventing the generation of cancer. Additional
studies will focus on the active components in joboksansam as well
as other pharmacologic effects such as anti-inﬂammatory activities.Conﬂicts of interest
Authors declare no conﬂicts of interest.References
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